chr17-72123970-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000346.4(SOX9):c.1113G>A(p.Ala371Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0246 in 1,467,744 control chromosomes in the GnomAD database, including 725 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 85 hom., cov: 32)
Exomes 𝑓: 0.025 ( 640 hom. )
Consequence
SOX9
NM_000346.4 synonymous
NM_000346.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.14
Genes affected
SOX9 (HGNC:11204): (SRY-box transcription factor 9) The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-72123970-G-A is Benign according to our data. Variant chr17-72123970-G-A is described in ClinVar as [Benign]. Clinvar id is 196257.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-72123970-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0729 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOX9 | NM_000346.4 | c.1113G>A | p.Ala371Ala | synonymous_variant | 3/3 | ENST00000245479.3 | NP_000337.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOX9 | ENST00000245479.3 | c.1113G>A | p.Ala371Ala | synonymous_variant | 3/3 | 1 | NM_000346.4 | ENSP00000245479.2 | ||
SOX9-AS1 | ENST00000414600.1 | n.96+17715C>T | intron_variant | 3 | ||||||
ENSG00000288605 | ENST00000628742.2 | n.147-38925C>T | intron_variant | 5 | ||||||
ENSG00000288605 | ENST00000674828.1 | n.304-78446C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0223 AC: 3372AN: 151152Hom.: 81 Cov.: 32
GnomAD3 genomes
AF:
AC:
3372
AN:
151152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0310 AC: 5062AN: 163086Hom.: 210 AF XY: 0.0264 AC XY: 2428AN XY: 92062
GnomAD3 exomes
AF:
AC:
5062
AN:
163086
Hom.:
AF XY:
AC XY:
2428
AN XY:
92062
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0249 AC: 32727AN: 1316482Hom.: 640 Cov.: 37 AF XY: 0.0242 AC XY: 15749AN XY: 650858
GnomAD4 exome
AF:
AC:
32727
AN:
1316482
Hom.:
Cov.:
37
AF XY:
AC XY:
15749
AN XY:
650858
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0224 AC: 3386AN: 151262Hom.: 85 Cov.: 32 AF XY: 0.0227 AC XY: 1681AN XY: 73930
GnomAD4 genome
AF:
AC:
3386
AN:
151262
Hom.:
Cov.:
32
AF XY:
AC XY:
1681
AN XY:
73930
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
24
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 14, 2014 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Camptomelic dysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Connective tissue disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Jul 22, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at